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Combining source collision-induced dissociation (CID) and tandem mass spectral acquisition
in a pseudo-MS3 experiment using a linear ion trap results in a highly selective and sensitive
approach to identifying glycopeptide elution from a protein digest. The increased sensitivity
is partially attributed to the nonselective nature of source CID, which allows simultaneous
activation of all charge states and coeluting glycoforms generating greater ion abundance for
the mass-to-charge (m/z) 204 and/or 366 oxonium ions. Unlike source CID alone, a pseudo-
MS3 approach adds selectivity while improving sensitivity by eliminating chemical noise
during the tandem mass spectral acquisition of the oxonium ions in the linear ion trap.
Performing the experiments in the hybrid linear ion trap/Fourier transform-ion cyclotron
resonance (FT-ICR) enables subsequent high-resolution/high-mass accuracy full-scan mass
spectra (MS) and parallel acquisition of MS/MS in the linear ion trap to be completed in 2 s
directly following the pseudo-MS3 scan to collate identification and characterization of
glycopeptides in one experimental scan cycle. Analysis of bovine fetuin digest using the
combined pseudo-MS3, high-resolution MS, and data-dependent MS/MS events resulted in
identification of four N-linked and two O-linked glycopeptides without enzymatic cleavage of
the sugar moiety or release of the sialic acids before analysis. In addition, over 95% of the total
protein sequence was identified in one analytical run. (J Am Soc Mass Spectrom 2006, 17,
168–179) © 2006 American Society for Mass SpectrometryRecent developments in biological mass spec-trometry have made protein sequencing routine,thereby allowing a deeper research focus on
posttranslational modifications (PTMs) at the cellular
level. Protein glycosylation is of particular interest since
it is the most common protein modification [1–5].
Glycosylation plays a crucial role not only in protein
structure but also in cell-cell recognition, and perhaps
even signaling mechanisms [6 – 8]. Therefore, the anal-
ysis of protein glycosylation is of the utmost importance
if its biological roles are to be understood and evalu-
ated. To adequately describe glycosylation, three pieces
of information are required: (1) identification of the
glycosylated proteins and peptides, (2) the site(s) of the
glycosylation, and (3) the structure of the glycan [2].
Obtaining this information is challenging since the
oligosaccharide modification is highly heterogeneous.
There are no clearly defined mass shifts as those for
oxidation, phosphorylation, or acetylation. And unlike
other PTMs, a mass shift for glycosylation can greatly
exceed that of the peptide altering elution properties.
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doi:10.1016/j.jasms.2005.10.008The most common approach used to identify glyco-
sylated peptides employs detection of diagnostic sugar
oxonium-ion fragments on a single or triple quadrupole
mass spectrometer [2, 3, 9 –14]. The general method
used to create diagnostic ions employs CID in either the
source region (single quadrupole MS) or the collision
cell of a triple quadrupole instrument resulting in
dissociation of the oligosaccharide modification [2, 3, 5,
9 –15]. Detection of the diagnostic sugar oxonium-ion
fragments can be used to trigger additional scans with-
out CID to obtain intact molecular weights. Carr and
coworkers [10, 11, 13] and Dziegielewska et al. [16] have
performed extensive analysis on numerous diagnostic
ions generated by CID to evaluate optimal signals that
can be used to signify glycopeptide elution from an LC
separation. Typically, the diagnostic fragment ions used
for precursor ion scanning include the oxonium ions of
hexose (Hex) at m/z 163, N-acetylhexosamine (HexNAc)
at m/z 204, and hexose-N-acetylhexosamine (Hex-Hex-
NAc) at m/z 366. However, the specificity of using the
above listed diagnostic fragment ions for glycopeptide
detection has been called into question since other
nonglycosylated peptides dissociated by CID may re-
sult in isobaric interferences to the characteristic re-
porter ions [2, 10].An alternative method for identifying glycosylated
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scanning provided by quadrupole time-of-flight (TOF)
instruments to increase the selectivity for detecting
precursor ions [2, 17, 18]. Jebanathirajah and coworkers
[2] increased selectivity using a mass tolerance of 0.02
Da for the detection of m/z 163, 204, and 366 reporter
ions of glycopeptides spiked into a complex digest
mixture [2]. Once peptides are identified as glycosy-
lated from the precursor ion scanning experiment (i.e.,
detection of m/z 163, 204, or 366), a tandem mass
spectral event is performed for sequencing information.
The limitations associated with this approach lie in
precursor ion scanning on a TOF instrument. The long
scan times (50 ms at a step size of 1 Da) needed to
analyze a mass range of 1000 Da prohibits protein
digest analysis on an LC time scale. Therefore, analyses
are generally performed via direct infusion, which may
lead to decreased sensitivity due to charge suppression
from simultaneous ionization of the complex protein
digest. In addition, the diagnostic ion intensity used to
trigger subsequent mass spectral events originates from
a single charge state of a single glycoform, which may
be significantly attenuated compared to the nonglyco-
sylated peptide response.
The experiments in this report, however, describe a
novel method to sensitively and selectively identify
glycopeptides on-line while simultaneously acquiring
high-resolution/high-mass accuracy full-scan data and
sequencing information using a hybrid linear ion trap/
FT-ICR mass spectrometer. Our approach is to combine
source CID with tandem mass spectral analysis of m/z
204 and/or 366 diagnostic ion(s) in the linear ion trap to
increase the detection capabilities without dramatically
increasing experimental time. The increase in sensitivity
is related to the physical attributes of a linear ion trap
[19] (e.g., fast ion fill times, high trap capacity, dual
orthogonal detection) that enable high-throughput
analysis of complex peptide mixtures that have tradi-
tionally been relegated to multiple mass spectrometers
for detection and characterization of glycopeptides. The
above mentioned approach capitalizes on coelution of
glycoforms, which results in simultaneous dissociation
of all glycoforms in the source region to produce an
increased diagnostic ion signal compared to activating a
single glycoform as in a precursor ion scan. Thus, the
short amount of time required to complete the pseudo-
MS3 survey scan enables subsequent full-scan and data-
dependent MS/MS experiments to be performed for
characterization.
Experimental
Chemicals and Reagents
Dithiothreitol, iodoacetamide, formic acid, and bovine
fetuin were purchased from Sigma (St. Louis, MO). The
bovine fetuin was used without further purification.
Trypsin was purchased from Promega (Madison, WI).
The glycopeptide standard was purchased from EMDBiosciences (San Diego, CA) as a lyophilized powder
that contained a mixture of glycoforms on the base
peptides GENR and NK originating from phospho-
lipase A2 [honeybee (Apis mellifica) venom gland ex-
tracts] [20]. HPLC-grade acetonitrile and water were
purchased from Burdick and Jackson (Muskegon, MI).
Sample Preparation
The glycopeptide standard was reconstituted in water
to give a stock solution of 200 pmol L1. All dilutions
were made from the stock solution with water and
analyzed without further purification. A 1 mg mL1
solution of bovine fetuin was digested with trypsin
using a standard protocol [21]. Amounts reported on
column are based on the stock solution from the glyco-
peptide standard mixture and the original amount used
during the fetuin digestion. Dilutions of the enzymatic
digestion were done using a 0.1% formic acid solution
before injection.
LC-MS and MSn Analysis
HPLC. A binary solvent system composed of H2O
containing 0.1% formic acid (A) and MeCN containing
0.1% formic acid (B) was used for all analyses. A flow
rate of 50 Lmin1 consisting of 20% organic phase was
used for the analyses of the glycopeptide standard with
a total run time of 3 min. Five microliters were injected
onto a BioBasic C18 column with the dimensions of 100
 1 mm (Thermo Electron, Bellefonte, PA) for each
analysis with five replicate injections per level.
The bovine fetuin digest analyses were analyzed
using a gradient running from 5 to 45% B in 45 min,
holding at 45% B for three min, then immediately
increasing to 80% B for a column wash before column
equilibration at 5% B for the next injection. A 10 L
volume was injected per analysis.
Mass spectrometer. All analyses were performed on the
Finnigan LTQ-FT hybrid linear ion trap/FT-ICR mass
spectrometer (Thermo Electron, Bremen, Germany). A
detailed schematic of the hybrid instrument has been
described previously [22]. For all in-source collision-
induced dissociation analysis (source CID), a 92 V
potential offset was applied to ion optics following the
ion skimmer. Automatic gain control (AGC) target
values for full-scan MS data acquisition were main-
tained at 5e5 counts for detection in the ICR cell and 3e4
counts for detection in the linear ion trap. AGC target
values for MS/MS product ion detection were 5e5 and
1.5e4 counts for the ICR cell and linear ion trap, respec-
tively. One microscan was used for all full-scan mass
spectral data acquisition with the exception of MS/MS
product ion detection in the ICR cell, where two mi-
croscans were used. A resolving power of 100,000 (at
um/z 400) was used for all ion detection in the ICR cell.
cor
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glycopeptide standard was performed using both the
linear ion trap and the ICR cell for characterization and
evaluation of conversion efficiency of intact glycopep-
tides to the diagnostic sugar fragments m/z 204 and 366
resulting from source CID. Subsequent ion detection in
the ICR cell with and without source CID utilized the
high-resolution/mass accuracy to confirm intact and frag-
mented glycopeptide structural assignments. The sensitiv-
ity of the pseudo-MS3 survey scan was compared to
full-scan glycopeptide detection using integrated peak
areas from reconstructed ion chromatograms.
Bovine fetuin digest analysis. The enzymatic digest of
fetuin was analyzed using an experimental sequence
consisting of six scan events. A temporal representation
of the six scan event cycle and the site for the respective
data acquisition are presented in Figure 1. A pseudo-
MS3 survey scan was performed in scan event 1 with
mass spectral data acquired in the linear ion trap. This
scan employed 92 V of source CID enabling linear ion
trap collection, isolation, and dissociation of the result-
ing diagnostic HexNAc (m/z 204) ion in a true tandem
MS analysis. Scan event 2 utilized the ICR cell to acquire
a full-scan mass spectrum without source CID covering
a mass range of 400 to 1800 Da. During the high-
resolution full-scan transient acquisition, a low-resolu-
tion (ca. 25,000 at m/z 400) snapshot is recorded and
interrogated yielding mass-to-charge values for the
subsequent data-dependent MS/MS mass analyses per-
formed in scan events 3 to 6. Parallel acquisition of the
data-dependent MS/MS spectra was performed during
the completion of the high-resolution mass spectral
detection in scan event 2 to maximize experimental
cycle time and provide sequence coverage. Source CID
was not employed for scan events 2 to 6. In addition,
Figure 1. Plot of the approximate temporal rel
and characterizing modified and unmodified enz
refers to data acquisition in the ICR cell and LITDynamic Exclusion was employed to increase peptidecoverage using a repeat count of 1. That is, once a
precursor mass-to-charge value was identified and used
to trigger a data-dependent MS/MS event, the precur-
sor mass-to-charge value was placed on an exclusion
list for 20 s to eliminate triggering an additional data-
dependent event on the same mass-to-charge value. The
resulting MS/MS data were analyzed using Bioworks
version 3.2 (Thermo Electron, Bremen, Germany) to
identify unmodified peptides [23]. The search criterion
used to initially match in silico enzymatic peptides to
experimentally determined peptide molecular weights
was set to 5 ppm to provide additional confidence in the
Bioworks search output.
Qualitative analysis of the glycopeptides was done
using two different programs. First, the program Xtract
(Thermo Electron, Bremen, Germany) was used to con-
vert the raw data into singly charged monoisotopic
spectra for easy interpretation of protonated molecular
ions. Then, the reported accurate mass of the proton-
ated molecular ion was used to search possible oligo-
saccharide structures and compositions using Glyco-
Mod (http://us.expasy.org/cgi-bin/glycomod.pl) from
the Swiss-Prot website [24, 25]. Glycopeptides and
glycoforms previously reported by Medzihradszky et
al. were used for comparison and confirmation [6, 26].
Results and Discussion
The utility of performing precursor ion scanning for
detection of glycopeptides is particularly attractive
since glycopeptide fragmentation yields predominantly
N-acetylhexosamine (HexNAc) or hexose-N-acetylhex-
osamine (Hex-HexNAc) following collision-induced
dissociation, making it essentially universal for glyco-
peptide detection. However, precursor ion scanning is a
slow, relatively insensitive technique due to the poor
ship for the six scan events used for identifying
tic peptides in one analytical experiment. The FT
responds to linear ion trap detection.ation
ymaduty cycle that results from scanning Q1. In addition, its
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high-resolution capabilities has been called into ques-
tion [2]. Yet, it offers the advantage of identifying the
mass-to-charge ratio of each of the glycoforms present.
To improve upon precursor ion scanning, a new
method would need to be faster, more sensitive, and/or
add selectivity. All three of these attributes can be
found in a combined source CID, tandem MS approach
to detecting glycopeptides.
Generating diagnostic oxonium ions from glycopep-
tides in the skimmer region of a mass spectrometer has
been well described in the literature [5, 10, 14, 27]. In
brief, a high potential is placed on the ion optics
following the skimmer, such that ions are accelerated in
a region that has moderate pressure, causing ion frag-
mentation. A primary limitation associated with source
CID is the lack of selectivity as to which ions are
fragmented. However, for the analysis of glycopep-
tides, this feature can be a positive attribute. Under
reverse phase LC conditions, glycopeptides typically
are present as multiple coeluting glycosylated forms of
different mass and/or charge states [18]. Employment
of source CID to identify glycopeptide elution is an
attractive proposition because of this coelution of gly-
coforms. Since ion activation is accomplished in the
high-pressure region of the ion stack, all ions formed at
a given retention time are subjected to collision-induced
dissociation. Thus, multiple glycoforms can contribute
to the intensity of the diagnostic oxonium ions simul-
Figure 2. High-resolution full-scan mass spec
standard mixture. The expanded mass region di
with the predicted oligosaccharide structure. T
represent Hex, and filled triangles represent fuc
monoisotopic peak for the observed 2 charge
presented.taneously. Taking advantage of the nonselective natureof source CID to produce more m/z 204 and 366 diag-
nostic fragment ions enables greater sensitivity than
attempting to fragment and detect each glycoform
independently, as is the case in a precursor ion scan.
Glycopeptide Standard Mixture Results
Preliminary studies used to evaluate the survey scan for
identification of glycopeptides at varying concentra-
tions were performed on a standard containing glyco-
forms of two peptides with the amino acid composi-
tions NK and GENR, where the oligosaccharide motif
constitutes ca. 1200 Da [20]. The large mass difference
between the amino acid backbone and the oligosaccha-
ride modification results in the sugar modification
dominating chromatographic properties. That is, all
glycoforms were observed coeluting immediately fol-
lowing the void volume despite using a mobile phase
composition of 20% organic. Figure 2 shows a full-scan
spectrum for ca. 1 pmol of the glycopeptide mixture
acquired in the ICR cell. The inset shows that all
glycopeptides are present in the 2 charge state with
five different glycoforms being identified using high
mass accuracy and multiple stages of MSn (data not
shown). For example, the base peak component (m/z
887.4) was identified as containing the peptide back-
bone GENR glycosylated with HexNAc4-Hex3 and the
m/z 780.3 ion was identified as the dipeptide NK
modified with the same oligosaccharide. The average
acquired in the ICR cell for the glycopeptide
s the multiple glycoforms present in the sample
pen squares represent HexNAc, filled squares
he calculated mass measurement errors for the
es are in reference to the theoretical structuretrum
splay
he o
ose. T
statmass error for the five glycopeptides was 1.16 ppm.
linea
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dard mixture, source CID was performed to generate
the diagnostic oxonium ions. Previous work on a 3-D
ion trap instrument showed that source parameters had
to be altered to produce strong diagnostic oxonium ions
[27]. For example, optimal settings reported for the tube
lens and capillary voltage used to generate strong
diagnostic oligosaccharide ion signals were 100 and 75
V, respectively, compared with standard operating pa-
rameters of 10 and 30 V. In addition, the capillary
temperature was increased from 130 ° to 175 °. Results
obtained on the linear ion trap in the current studies
showed that substantial signal for m/z 204 was obtained
by simply setting the source CID offset to 92 V with no
adjustment to the capillary temperature. Figure 3a
shows a high-resolution full-scan mass spectrum of the
glycopeptide standard mixture for the low mass range
(100–400 Da) with source CID employed. The base
peak in the spectrum is them/z 204 ion, which is directly
attributed to the C8H14NO5
 ion representing N-acetyl-
hexosamine (HexNAc). In addition, two other charac-
teristic sugar fragments are observed at m/z 366 (Hex-
HexNAc) and m/z 186 (HexNAc  H2O). Each of the
diagnostic fragment ions had measured mass accuracies
of 1.7 ppm or less for the proposed elemental compo-
sitions giving high confidence in the correct identifica-
tion. In fact, even increasing the mass tolerance to 5
ppm would not result in a plausible secondary ion
Figure 3. Full-scan and MS2 mass spectra of di
of 92V from the glycopeptide standard mixture. (
Da) with mass errors listed. The tandem mass sp
Hex-HexNAc ion at m/z 366 (c) acquired in thecomposition.It is clear from the full-scan mass spectrum displayed
in Figure 3a that there are numerous product ions
formed in addition to the m/z 204 and 366 diagnostic
ions during source CID. The chemical background
generated by source CID may limit the sensitivity and
dynamic range for the detection of the diagnostic ions
since the ion trap mass spectrometer operates using
automatic gain control (AGC) to limit the number of
ions that are collected for each mass spectrum. While
using a 3-D ion trap to detect diagnostic oxonium ions
generated by source CID, Sullivan et al. [27] found that
they achieved the best sensitivity by utilizing SIM
mode. This is not surprising since SIM and MSn modes
on an ion trap mass spectrometer increase the sensitiv-
ity and dynamic range of the instrument by overfilling
the trap and then isolating the correct amount of the
ions of interest using a waveform. Unfortunately, the
use of SIM mode does not add any selectivity to the
source CID experiment. That is, during the elution of an
enzymatic digest, nonglycosylated peptides may disso-
ciate to form a m/z 204 or 366 product ion that is not an
oxonium ion, resulting in a false positive for glycopep-
tides [2]. Although the method employed by Sullivan et
al. using diagnostic ion detection by SIM showed evi-
dence of glycopeptide elution, the method showed
much greater promise following protein treatment with
neuramidase to dramatically reduce the glycopeptide
complexity. To achieve greater selectivity without the
stic oxonium ions acquired using in-source CID
-ICR detection for the lowmass region (100–400
for both the HexNAc ion at m/z 204 (b) and the
r ion trap are displayed.agno
a) FT
ectrause of neuramidase, a source CID MS/MS scan (pseu-
e und
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the basis of our approach to glycopeptide detection.
Performing a true tandem mass spectral event in the
linear ion trap following source CID dramatically in-
creases sensitivity and selectivity by first isolating the
m/z 204 product ion (or m/z 366), then using identifica-
tion of known tandem mass spectral product ions for
glycopeptide confirmation. Figure 3 shows an MS/MS
spectrum for the (Figure 3b) m/z 204 and (Figure 3c) m/z
366 diagnostic sugar ions following source CID. Each
tandem mass spectrum was acquired in the linear ion
trap using one microscan resulting in ca. 0.5 s of
acquisition time. Note the low background signal from
the MS/MS spectra with only product ion detection
from the m/z 204 and 366 precursor ions. The relative
abundance of the m/z 366 precursor ion was only 10% of
the m/z 204 base peak observed in Figure 3a, yet a clean
and rich product ion spectrum dominated by a m/z 204
product ion. The pseudo-MS3 product ions can then be
used for post-acquisition filtering to identify glycopep-
tide elution, or online as an SRM for fraction collecting.
Although the source CID event in the linear ion trap
mass spectrometer is not as selective as a precursor scan
on a triple quadrupole, the subsequent MS/MS event in
the linear ion trap provides the necessary selectivity to
confirm the presence of glycopeptide elution.
Determination of glycopeptide detection capabilities
using a pseudo-MS3 survey scan was performed on the
standard glycopeptide mixture. Previous means of
identifying glycopeptides in an ion trap utilized data-
dependent MS/MS scanning triggered from the prior
Figure 4. Extracted ion chromatogram for the
at (a) 25 and (b) 250 fmol injected on column. T
displayed in (c) 25 fmol and (d) 250 fmol. A
mass-to-charge values for known glycoforms arfull-scan mass spectrum [4, 28]. Since this has been theprimary method for characterizing glycopeptides using
ion traps, full-scan mass spectral detection capabilities
were compared to results using the combination source
CID-MS/MS approach. Figure 4 shows two extracted
ion chromatograms for the m/z 887 ion and the corre-
sponding full-scan mass spectrum at the elution maxi-
mum of the standard glycopeptide mixture. The two
levels displayed correspond to 25 fmol (Figure 4a), and
250 fmol (Figure 4b) on column. Note that the retention
times are directly following the void volume of the C18
column despite a mobile phase composition of 20%
organic. The full-scan mass spectra presented in Figure
4c showed a minor peak at m/z 887 for 25 fmol of the
standard glycopeptide mixture on column but no other
glycoform could be identified. The signal intensity of
the m/z 887 ion would be difficult for data-dependent
scanning to select and perform automated tandemmass
spectral data acquisition because of the relative inten-
sity of the m/z 887 ion to that of the background.
Consequently, omitting the precursor glycopeptide
mass from data dependent MS/MS analysis would
significantly decrease identification capabilities. Figure
4b shows the extracted ion chromatogram for the m/z
887 ion with 250 fmol on column. The integrated peak
for the m/z 887 ion is significantly greater than the
background. The mass spectrum (Figure 4d) shows not
only the primary N-linked glycopeptide (GENR), but
the m/z 780 and 830 representing N-linked glycoforms
of NK. At 250 fmol on column, the ion intensity for the
m/z 887 and 780 precursor ions would be sufficient to
87 ion from the glycopeptide standard mixture
erage full-scan mass spectrum for each level is
ta were acquired in the linear ion trap. The
erlined.m/z 8
he av
ll datrigger a data-dependent MS/MS event.
ns fr
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source CID (92 V) and performing tandem mass spec-
tral analysis of m/z 204. Figure 5 shows the extracted ion
chromatogram for the summation of m/z 126 and 186
MS/MS product ions for 25 fmol (Figure 5a) and 250
fmol (Figure 5b) of the standard glycopeptide mixture
injected on column. Figure 5c shows the resulting
full-scan product ion spectrum of m/z 204 acquired at
the apex of the elution peak. The m/z 163 base peak ion
results from a chemical interference in the m/z 204
isolation window. Despite the interference from the m/z
163 ion, an integrated chromatographic peak can be
reconstructed using the m/z 126 and 186 product ions,
which were only 5% of the base peak. Thus, the selec-
tivity of utilizing a pseudo-MS3 survey scan can be
dramatically improved when filtering the MS2 data for
known product ions of the HexNAc oxonium ion at m/z
204.
Figure 5b shows the extracted ion chromatogram for
the m/z 126 and 186 ions for 250 fmol on column. The
integrated peak area was calculated to be 9.6 times
greater than that for the peak area for 25 fmol on
column, indicating a great potential for quantitative
experiments to be performed. Figure 5d shows the
survey scan for 250 fmol on column. The underlined
product ions correspond to diagnostic fragments for the
HexNAc oxonium ion. Note that all of the product ions
displayed in Figure 3b are present in Figure 5d even
though the amount on column has been reduced by a
Figure 5. Extracted ion chromatograms for the s
by the pseudo-MS3 survey scan of the diagno
standard mixture at (a) 25 fmol and (b) 250 fmol
in the linear ion trap. The full-scan tandem
corresponding level injected. Known product iofactor of four.Fetuin Analysis Results
Analysis of more complex mixtures of modified and
native peptides was done using an enzymatic digestion
of fetuin. Fetuin is ideally suited to determine the
effectiveness of the pseudo-MS3 survey scan because of
the high degree of glycosylation. In addition, bovine
fetuin has been well studied, with the sequence and
oligosaccharide modifications published [6, 12, 26, 29].
Figure 6a shows a base peak plot for the enzymatic
digest of fetuin with the peptide map associated to the
corresponding elution peaks. A base peak plot is used
to represent the ion intensity of the most intense full-
scan MS ion at each point in the chromatogram and
generally yields a more interpretable chromatogram.
The fetuin sequence used for the peptide mapping was
that published by Medzihradszky et al. [26] Figure 6b
shows the extracted ion chromatogram for the m/z 126
product ion following source CID and MS/MS analysis
of the m/z 204 diagnostic HexNAc ion detected in the
linear ion trap. Glycopeptide assignments resulted from
full-scan accurate mass data comparison with reported
structures from previous publications [6, 26]. Note that
the intense peaks in Figure 6b identified as glycopep-
tides correspond to peaks with low relative intensity in
Figure 6a. For example, the base peak in Figure 6b
identified as the N-linked glycopeptide T127–141 eluting
at 15.5 min has a relative abundance of ca. 10% to the
T11–32 peptide eluting at 15.8 min shown in Figure 6a.
ation ofm/z 126 and 186 product ions generated
xonium ion at m/z 204 from the glycopeptide
ted on column. All ion detection was performed
s spectra for each level is shown below the
om HexNAc are underlined.umm
stic o
injec
masFigure 6c shows an extracted ion chromatogram
. Not
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reported from Medzihradszky et al. The ions used to
construct the chromatographic trace for Figure 6c rep-
resents each of the proposed N- and O-linked glycopep-
tides and are labeled with the corresponding mass-to-
charge value, and predominant charge state detected
from the full-scan mass analysis in the ICR cell. All
extracted ion chromatograms for the proposed glyco-
peptides of fetuin align with the primary peaks identi-
fied using the pseudo-MS3 survey scan (Figure 6b). The
excellent agreement between the proposed glycopep-
tides (Figure 6c) and the experimentally identified gly-
copeptides (Figure 6b) demonstrates that excellent se-
lectivity is achieved using a pseudo-MS3 survey scan
approach without enzymatically releasing sialic acids
before mass spectral analysis.
Since the survey scan does not acquire the high mass
range, a full-scan mass spectrum without source CID is
acquired directly following the survey scan. The subse-
quent full-scan spectra enable determination of intact
peptide masses at the chromatographic elution of the
diagnostic HexNAc ions. Using only a source CID offset
voltage for generation of the diagnostic sugar ions
enables optimum spraying conditions for full scan mass
analysis in the same analytical experiment.
The elution time at 17.7 min is a good representation
of the time requirements to complete all six scan events
while a suspected glycopeptide is eluting. A total of
1.7 s of experimental time was needed to acquire a
Figure 6. Base peak plot and extracted ion chro
describing the peptide and glycopeptide elution
for unmodified peptides. The pseudo-MS3 surve
are depicted as an extracted ion chromatogram f
(c) Illustrates where the previously reported gl
summation of extracted ions from the literaturepseudo-MS3 survey scan and a full-scan mass spectrum.The ion flux of the eluting glycopeptides does not
change significantly during the 0.5 s needed for survey
scan acquisition so the subsequent MS and MS/MS
events give a good reflection of the intact precursor ions
detected in the survey scan. In addition, parallel detec-
tion of four full-scan data-dependent MS/MS scans
were acquired in the same 1.2 s as that for high-
resolution/accurate mass data acquisition. The result-
ing MS/MS spectra were used to sequence the N-linked
sugar moiety of the 4 and 5 charge states for each of
the N-linked glycoforms of residues T54–85 eluting at
17.7 min. Figure 7 shows a high-resolution/high-mass
accuracy full-scan mass spectrum for the elution peak
identified as the T54–85 glycopeptide containing
Hex5HexNAc4Neu5Ac3 (m/z 1176.7 for the 5 charge
state and m/z 1470.7 for the 4 charge state) and
Hex6HexNAc5Neu5Ac3 (m/z 1308.0 for the 5 charge
state and m/z 1634.7 for the 4 charge state). The
peptide sequence and oligosaccharide structures used
for each labeled glycoform were adapted from previ-
ously reported structures. The monoisotopic peak for
each ion is labeled with the corresponding mass accu-
racy. Note that the mass errors reported are better than
2 ppm using external calibration regardless of the
relative ion abundance. The survey scan, which was
acquired directly before the full-scan mass spectrum, is
shown in the inset. The diagnostic HexNAc fragment
ions are labeled and contain all of the same fragment
ions as that detected for the glycopeptide standard mix
grams for the enzymatic digest of bovine fetuin
iles. The FT-ICR base peak plot is shown in (a)
n results indicating the elution of glycopeptides
e m/z 126 product ion from the HexNAc ion (b).
eptide ions of bovine fetuin were eluting as a
e the agreement between (b) and (c).mato
prof
y sca
or th
ycopshown in Figure 3b despite a different oligosaccharide
ons f
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standards that was used for method development
work.
In addition to the survey scan and high-resolution/
mass accuracy spectrum acquired for the identification
of the glycoforms for the T54–85 peptide, oligosaccharide
sequencing was accomplished during the parallel data-
Figure 7. Full-scan mass spectrum for the reten
with the oligosaccharide structures and mass ac
filled squares represent Hex, and open triangles
acquired directly before the high-resolution/hig
relative intensity of the characteristic fragment i
Figure 8. Full-scan data-dependent MS/MS sp
tide precursor ions acquired in the linear ion trap.dependent MS/MS events. Figure 8 shows the resulting
full-scan MS/MS spectra for the 4 charge state pre-
cursor ions of the T54–85 glycoforms m/z 1470 and m/z
1634, for comparison. Using the parallel detection capa-
bility of the LTQ-FT, the product ion spectra were
acquired in the linear ion trap while the full-scan mass
detection occurred in the ICR cell to decrease the total
time of 17.6 min showing two T54–85 glycoforms
ies listed. The open squares represent HexNAc,
esent Neu5Ac. The inset shows the survey scan
ass accuracy spectrum acquisition showing the
rom HexNAc.
for the (a) m/z 1470 and (b) m/z 1635 glycopep-tion
curac
repr
h-mectra
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each figure is used to identify fragment ions resulting in
the characterization of each oligosaccharide modifica-
tion. Note the number of similar product ions resulting
from each glycoform analyzed such as the m/z 1293,
1591, 1688, 1766, and 1864 ions indicating a similar core
oligosaccharide structure. From the tandem mass spec-
tra, a total of two sialic acids were associated to the
oligosaccharide motif linked to the m/z 1470 glycoform
and three for the m/z 1634 glycoform.
An additional LC-MS/MS/MS analysis was per-
formed employing product ion detection in the ICR cell
for high-resolution/high-mass measurement accuracies
for confirmation of product ion assignment (data not
shown). Measured mass accuracies for similar product
ions resulting from m/z 1470 and 1635 ions can be used
for further confirmation of glycoform compositions. For
example, the m/z 1293 product ion identified as the
peptide backbone and a N-acetylhexosamine has a
measured mass accuracy of 1.76 ppm resulting from the
m/z 1470 precursor ion analysis compared with 1.93
ppm from the m/z 1635 ion as well as accuracies of 0.57
and 1.88 ppm for the m/z 1590.7 product ion from m/z
1470 and 1635, respectively, resulting in high confi-
dence in the assignment of T54–85 HexNAc3Hex3.
Table 1 summarize the glycopeptides and corre-
sponding glycoforms from the enzymatic digest of
fetuin identified via the pseudo-MS3 survey scan anal-
ysis. The protonated molecular masses were calculated
using Xtract and compared with the predicted theoret-
ical chemical formula. In addition, the relative ion
abundance of the protonated molecular ion detected at
the apex of the reconstructed elution peak for each
glycoform is listed. The mass accuracies for all of the
Table 1. List of the identified glycopeptides and corresponding
enzymatic digestion of bovine fetuin. The molecular weight of th
Xtract. The reported relative abundance and observed retention t
presented
Sequence (oligosaccharide composition) Position
KL*CPD*CPLLAPLNDSR 126–141
Hex6HexNAc5Neu5Ac3 100%
L*CPD*CPLLAPLNDSR 127–141
Hex5HexNAc4Neu5Ac2 61%
Hex6HexNAc5Neu5Ac3 100%
Hex6HexNAc5Neu5Ac4 21%
VT*CTLFQTQPVIPQPQPDGAEAEAPSAVPDA-
AGPTTPSAAGPPVASVVVGPSVVAVPLPLHR
228–288
Hex2HexNAc2Neu5Ac3 3%
Hex3HexNAc3Neu5Ac3 3%
Hex3HexNAc3Neu5Ac4 2%
RPTGEVYDIEIDTLETT*CHVLDPTPLAN*CSRV 54–88
Hex5HexNAc4Neu5Ac2 24%
Hex6HexNAc5Neu5Ac3 100%
Hex6HexNAc5Neu5Ac4 7%
VVHAVEVALATFNAESNGSYQLVEISR 142–169
Hex6HexNAc5Neu5Ac3 100%glycoforms identified were better than 3 ppm using themonoisotopic masses for the singly charged species. In
fact, only the O-linked glycopeptides T228–288 and the
N-linked glycopeptide T54–85 containing the oligosac-
charide Hex5HexNAc4Neu5Ac2 show mass errors
greater than 2 ppm. Note the relative abundance mea-
sured for the O-linked glycoforms are no greater than
3% of the base peak during elution, yet excellent mass
measurement accuracies result in high confidence in the
assigned chemical structure for each of the glycoforms.
In addition to identifying the glycopeptides from the
fetuin digest, protein sequence information was also
acquired in one run. The full scan mass spectra acquired
directly following the glycopeptide survey scan was
used to direct data-dependent MS/MS experiments
resulting in peptide sequencing information. Table 2
lists the enzymatic peptides identified using Bioworks
Browser 3.2 which incorporates accurate mass of the
precursor ions to increase confidence in peptide se-
quence assignment. In addition to the sequence and
mass error, the cross-correlation (X-corr) scores re-
ported from Bioworks are provided to evaluate good-
ness of fit between the experimental and theoretical
MS/MS spectra. Note the X-corr values reported for
precursor ions identified in the 1 charge state are
sufficient for consideration. That is, a generally ac-
cepted X-corr value for peptides detected in the 1
charge state is 1.5 and the average X-corr for the eight
identified singly charged peptides is 1.535, indicating
that a significant number of experimental b- and y-type
fragment ions were matched to in silico fragmentation
spectra [23]. In addition, the average mass error for the
eight peptides was 0.42 ppm increasing confidence in
the assigned peptide sequence. Including the glycopep-
tides identified using accurate mass and tandem mass
forms for the N- and O-linked oligosaccharides from the
 H] used for the experimental mass was calculated using
R.T.) from the apex of the corresponding elution peak is
R. T.
(min)
Experimental
mass
Theoretical
mass
Mass
error
(ppm)
13.27 4729.93994 4729.93576 0.884
15.50 3945.61597 3945.61319 0.706
15.51 4601.84082 4601.84080 0.004
15.51 4892.93604 4892.93622 0.037
16.76 7620.70898 7620.68980 2.52
16.76 7983.79395 7983.81529 2.67
17.30 8274.92969 8274.91070 2.29
17.69 5876.55371 5876.54042 2.26
17.69 6532.77930 6532.76804 1.72
17.69 6823.86279 6823.86345 0.100
18.27 5877.57422 5877.57388 0.058glyco
e [M
ime (spectral analysis, a total of 325 of the reported 335
–335
178 PETERMAN AND MULHOLLAND J Am Soc Mass Spectrom 2006, 17, 168–179amino acid residues were identified from the Bioworks
search resulting in ca. 97% coverage. The ten residues
not identified include the T4 (GYK m/z 367) and T25 (VR
m/z 274) residues which fall below the mass range
originally acquired in the ICR cell.
Conclusions
A sensitive and selective method for glycopeptide de-
tection was presented using a hybrid linear ion trap/
FT-ICR mass spectrometer. Dissociation of glycopep-
tides in the source region and collection of the
subsequent fragment ions proved to be very efficient
using the LTQ-FT. Once collected in the linear ion trap,
true tandem mass spectral analysis of the m/z 204
diagnostic sugar ion provides a sensitive and selective
means for identification of glycopeptides despite coelu-
tion of unmodified peptides at greater ion intensities. In
addition, the subsequent five scan events provided not
only accurate mass analysis of intact molecular weights
but oligosaccharide structural information in ca. 2 s per
cycle. The combination of all three types of data acqui-
sition was sufficient to fully characterize protein struc-
ture and posttranslational modifications at five differ-
ent sites, including N- and O-linked oligosaccharides,
without having to enzymatically cleave the sugar moi-
ety before mass spectral analysis. Including the glyco-
peptide identification and characterization, 97% cover-
age was reported for the bovine fetuin enzymatic
digest.
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